The Role of Pyruvate Dehydrogenase Kinase in Diabetes and Obesity
Diabetes & Metabolism Journal
;
: 181-186, 2014.
Article
in English
| WPRIM
| ID: wpr-55008
ABSTRACT
The pyruvate dehydrogenase complex (PDC) is an emerging target for the treatment of metabolic syndrome. To maintain a steady-state concentration of adenosine triphosphate during the feed-fast cycle, cells require efficient utilization of fatty acid and glucose, which is controlled by the PDC. The PDC converts pyruvate, coenzyme A (CoA), and oxidized nicotinamide adenine dinucleotide (NAD+) into acetyl-CoA, reduced form of nicotinamide adenine dinucleotide (NADH), and carbon dioxide. The activity of the PDC is up- and down-regulated by pyruvate dehydrogenase kinase and pyruvate dehydrogenase phosphatase, respectively. In addition, pyruvate is a key intermediate of glucose oxidation and an important precursor for the synthesis of glucose, glycerol, fatty acids, and nonessential amino acids.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Oxidoreductases
/
Phosphotransferases
/
Acetyl Coenzyme A
/
Pyruvate Dehydrogenase Complex
/
Carbon Dioxide
/
Adenosine Triphosphate
/
Coenzyme A
/
Pyruvate Dehydrogenase (Lipoamide)-Phosphatase
/
Pyruvic Acid
/
Diabetes Mellitus
Language:
English
Journal:
Diabetes & Metabolism Journal
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS